Matches in Nanopublications for { ?s ?p "[Almost all CCPRCC-like tumors (82%) lacked the characteristic immunoprofile of sporadic CCPRCC (CK7, CAIX, CD10, AMACR), often showing diffuse CD10 labeling (64%), negative or focal CK7 reactivity (55%), or both (18%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP703081.RATWh-r4OS2g0dPA0s3Ty-O5i4_5CFhZZOWMuyZFdjSTo130_assertion description "[Almost all CCPRCC-like tumors (82%) lacked the characteristic immunoprofile of sporadic CCPRCC (CK7, CAIX, CD10, AMACR), often showing diffuse CD10 labeling (64%), negative or focal CK7 reactivity (55%), or both (18%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703081.RATWh-r4OS2g0dPA0s3Ty-O5i4_5CFhZZOWMuyZFdjSTo130_provenance.
- NP816282.RADWKdHbxq0HtKkPJyIsYAR8ehv2tVcHkDVeKn7r_fnbQ130_assertion description "[Almost all CCPRCC-like tumors (82%) lacked the characteristic immunoprofile of sporadic CCPRCC (CK7, CAIX, CD10, AMACR), often showing diffuse CD10 labeling (64%), negative or focal CK7 reactivity (55%), or both (18%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816282.RADWKdHbxq0HtKkPJyIsYAR8ehv2tVcHkDVeKn7r_fnbQ130_provenance.
- NP265401.RAwA3agU8jCb5bigCqkbha7ObT8wswzbtYAe9yeG-mWhg130_assertion description "[Almost all CCPRCC-like tumors (82%) lacked the characteristic immunoprofile of sporadic CCPRCC (CK7, CAIX, CD10, AMACR), often showing diffuse CD10 labeling (64%), negative or focal CK7 reactivity (55%), or both (18%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265401.RAwA3agU8jCb5bigCqkbha7ObT8wswzbtYAe9yeG-mWhg130_provenance.
- NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_assertion description "[Almost all CCPRCC-like tumors (82%) lacked the characteristic immunoprofile of sporadic CCPRCC (CK7, CAIX, CD10, AMACR), often showing diffuse CD10 labeling (64%), negative or focal CK7 reactivity (55%), or both (18%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658082.RA6Ceyg-hSuPS_fmZyhDgWqnz6rHTJMZlv3dY94qC8Lgo130_provenance.